The preoperative recurrence score: Predicting early recurrence in peri-hilar cholangiocarcinoma.

Eur J Surg Oncol

Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, University Hospital G.B. Rossi, Verona, Italy.

Published: December 2024

AI Article Synopsis

  • The study aims to develop a Preoperative Recurrence Score (PRS) to predict the risk of early recurrence in patients with perihilar cholangiocarcinoma (PCC) after surgery based on their preoperative imaging.
  • Researchers collected data from 215 patients and found significant tumor characteristics (like size and vascular involvement) correlated with recurrence-free survival, successfully validating the PRS model across multiple patient cohorts.
  • High PRS scores indicated a higher likelihood of recurrence, suggesting that surgery might not be beneficial for those patients, highlighting the need for careful consideration before proceeding to surgery.

Article Abstract

Introduction: Despite advances in surgical techniques, the rate of early recurrence in perihilar cholangiocarcinoma (PCC) remains high. We sought to develop the Preoperative Recurrence Score (PRS), a model to estimate the risk of early recurrence after resection based on preoperative radiological characteristics.

Materials And Methods: Data of patients who underwent surgery for PCC were retrospectively collected, and preoperative imaging was reviewed to assess tumor characteristics. A model to assess the risk of early recurrence based on preoperative radiologic characteristics was internally developed and externally validated on two cohorts of patients from two European major hepatobiliary surgery referral centers.

Results: A total of 215 patients among three different patient cohorts were included in the study. Tumor size ≥18 mm (HR 2.70, 95 % CI 1.48-4.92, p = 0.001), macroscopic portal vein involvement (HR 2.28, 95%CI 1.19-4.34, p = 0.013), hepatic arteries involvement (HR 2.44, 95%CI 1.26-4.71, p = 0.008), and presence of suspicious lymph nodes (HR 1.98, 95%CI 1.02-3.83, p = 0.043) were significantly associated with recurrence-free survival (RFS). The model showed excellent discrimination both on the internal (AUC 0.83) and external validation cohorts (external 1: AUC 0.84; external 2: AUC 0.70). High PRS was associated with worse RFS among all three cohorts, with a 1-year recurrence probability of 80.1 %, 100.0 %, and 54.2 % in the internal and external validation cohorts 1 and 2, respectively.

Conclusions: The PRS is a simple tool that can accurately assess the risk of early recurrence in patients with PCC. Up-front surgery should be carefully evaluated in patients with high PRS, as it could result in a futile resection.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2024.108745DOI Listing

Publication Analysis

Top Keywords

early recurrence
20
risk early
12
preoperative recurrence
8
recurrence score
8
based preoperative
8
assess risk
8
external validation
8
validation cohorts
8
external auc
8
high prs
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!